26 April 2021

Tridek-One – new member

 Tridek-One is a biotechnology company focused on developing first in class immunomodulatory products targeting the CD31 pathway. We are exploring a new approach for the management of immuno-inflammatory diseases. Our product has an holistic approach allowing a modulation of the immune response when overactivated.. To know more